Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

The Securities Arbitration Law Firm of Klayman & Toskes Investigates Claims of Molycorp Shareholders Who Held Large Concentrated Positions in Molycorp Stock With Full-Service Brokerage Firms

The Securities Arbitration Law Firm of Klayman & Toskes Investigates Claims of Molycorp Shareholders Who Held Large Concentrated Positions in Molycorp Stock With Full-Service Brokerage Firms

The Securities Arbitration Law Firm of Klayman & Toskes, P.A. (“K&T”), www.nasd-law.com, announced today that it is investigating claims of Molycorp, Inc. (NYSE: MCP) shareholders who sustained investment losses due to an over-concentration of shares in Molycorp stock. Since May 2011, the price of Molycorp dropped from $77 per share and is currently trading at about $5.60 per share, representing a decline of about 93%. As a result of this decline, Molycorp shareholders who held large concentrated stock positions in Molycorp have sustained substantial losses.

Since 2000, K&T has pioneered the representation of High Net Worth (“HNW”) and Ultra-HNW clients who sustained investment losses as a result of holding large concentrated positions in a single security or sector, in a full-service brokerage account. The clients we represented and continue to represent include founders of public companies and key employees from virtually every industry who received large grants of stock, Rule 144 restricted stock or stock options. The claims, filed in the Financial Industry Regulatory Authority (“FINRA”) Arbitration Department f/k/a NASD and NYSE, focus on the mismanagement of the clients’ portfolios given the fact that there were risk management strategies that would have protected the value of the concentrated portfolio. Such risk management strategies include stop loss and limit orders, protective puts and collars. Stop loss orders, limit orders and protective puts provide an account with downside protection and an exit strategy should the stock decline in value. A hedge strategy, known as a “zero cost” collar, would have created a range of value that the portfolio would have maintained irrespective of the fluctuation and direction of the underlining stock price. The failure to use risk management strategies as well as the failure to “hedge” the value of a concentrated portfolio directly exposes an investor’s concentrated position to the fluctuations in the volatile securities markets.

The attorneys at K&T are dedicated to pursuing claims on behalf of investors who have suffered substantial investment losses. K&T, an experienced, qualified and nationally recognized securities litigation law firm, practices exclusively in the field of securities arbitration and litigation. If you wish to discuss this announcement or sustained losses of $750,000 or more as a result of holding a concentrated position in Molycorp stock in a full-service brokerage account, please contact Steven D. Toskes or Jahan K. Manasseh of Klayman & Toskes, P.A., at 888-997-9956, or visit us on the web at http://www.nasd-law.com.



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today